I agree. It might not even be that beneficial for CBIS, knowing the government tends to tailor these sorts of favors to the highest bidder (i.e., not CBIS).
If I weren't interested in CBIS' future I would call total BS on this move by the DEA, a move which is so transparently designed to help Big Pharma and not the cause of cannabis as medicine.
Knowing Dr Bob he might agree with me..
Either way, CBIS will move forward